Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
Title:
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial
Author:
Zhu, Feng-Cai Hou, Li-Hua Li, Jing-Xin Wu, Shi-Po Liu, Pei Zhang, Gui-Rong Hu, Yue-Mei Meng, Fan-Yue Xu, Jun-Jie Tang, Rong Zhang, Jin-Long Wang, Wen-Juan Duan, Lei Chu, Kai Liang, Qi Hu, Jia-Lei Luo, Li Zhu, Tao Wang, Jun-Zhi Chen, Wei